On October 3, 2024 press releases titled "Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of ...
In the race to harness the transformative power of generative AI, companies are betting big – but are they flying blind? As billions pour into gen AI initiatives, a stark realit ...